{
    "id": 221,
    "entrez_name": "TP53",
    "entrez_id": 7157,
    "name": "Deleterious Mutation",
    "description": "Deleterious mutations are mutations of TP53 with prior characterization demonstrating significant deleterious effect on TP53 protein function. Inactivating TP53 mutations prevent on target activity and efficacy of MDM2-TP53 interaction inhibitors.",
    "gene_id": 45,
    "type": "variant",
    "variant_types": [
        {
            "id": 47,
            "name": "missense_variant",
            "display_name": "Missense Variant",
            "so_id": "SO:0001583",
            "description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",
            "url": "http://www.sequenceontology.org/browser/current_svn/term/SO:0001583"
        }
    ],
    "civic_actionability_score": 78,
    "coordinates": {
        "chromosome": "17",
        "start": 7571720,
        "stop": 7590856,
        "reference_bases": null,
        "variant_bases": null,
        "representative_transcript": "ENST00000269305.4",
        "chromosome2": null,
        "start2": null,
        "stop2": null,
        "representative_transcript2": null,
        "ensembl_version": 75,
        "reference_build": "GRCh37"
    },
    "evidence_items": {
        "id": 517,
        "name": "EID517",
        "description": "In a study of 74 patients with head and neck squamous cell carcinoma, those with disruptive mutations in TP53 had shorter overall survival and a higher rate of locoregional recurrence than those without mutations or with nondisruptive mutations.",
        "disease": {
            "id": 37,
            "name": "Head And Neck Squamous Cell Carcinoma",
            "display_name": "Head And Neck Squamous Cell Carcinoma",
            "doid": "5520",
            "url": "http://www.disease-ontology.org/?id=DOID:5520"
        },
        "drugs": [],
        "rating": 3,
        "evidence_level": "B",
        "evidence_type": "Prognostic",
        "clinical_significance": "Poor Outcome",
        "evidence_direction": "Supports",
        "variant_origin": "Somatic",
        "drug_interaction_type": null,
        "status": "accepted",
        "type": "evidence",
        "source": {
            "id": 320,
            "name": "TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.",
            "citation": "Skinner et al., 2012, Clin. Cancer Res.",
            "citation_id": "22090360",
            "source_type": "PubMed",
            "asco_abstract_id": null,
            "source_url": "http://www.ncbi.nlm.nih.gov/pubmed/22090360",
            "open_access": true,
            "pmc_id": "PMC3251726",
            "publication_date": {
                "year": 2012,
                "month": 1,
                "day": 1
            },
            "journal": "Clin. Cancer Res.",
            "full_journal_title": "Clinical cancer research : an official journal of the American Association for Cancer Research",
            "status": "fully curated",
            "is_review": false,
            "clinical_trials": []
        },
        "variant_id": 221,
        "phenotypes": []
    },
    "variant_groups": [],
    "assertions": [],
    "variant_aliases": [],
    "hgvs_expressions": [],
    "clinvar_entries": [],
    "allele_registry_id": null
}